2024 Q3 Form 10-Q Financial Statement
#000009144024000051 Filed on July 18, 2024
Income Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
Revenue | $1.247B | $1.280B |
YoY Change | -2.9% | 0.34% |
Cost Of Revenue | $587.9M | $612.4M |
YoY Change | -4.27% | 3.2% |
Gross Profit | $659.5M | $667.5M |
YoY Change | -1.66% | -2.15% |
Gross Profit Margin | 52.87% | 52.15% |
Selling, General & Admin | ||
YoY Change | ||
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $24.60M | $24.60M |
YoY Change | -0.81% | 36.67% |
% of Gross Profit | 3.73% | 3.69% |
Operating Expenses | $335.4M | $305.8M |
YoY Change | 2.66% | -14.13% |
Operating Profit | $324.1M | $350.5M |
YoY Change | -5.76% | 7.48% |
Interest Expense | $1.100M | $400.0K |
YoY Change | -121.57% | -96.77% |
% of Operating Profit | 0.34% | 0.11% |
Other Income/Expense, Net | $20.60M | $18.70M |
YoY Change | 121.51% | 23.03% |
Pretax Income | $332.2M | $356.9M |
YoY Change | -4.57% | 8.51% |
Income Tax | $74.70M | $79.30M |
% Of Pretax Income | 22.49% | 22.22% |
Net Earnings | $251.1M | $271.2M |
YoY Change | -4.89% | 9.05% |
Net Earnings / Revenue | 20.13% | 21.19% |
Basic Earnings Per Share | $4.77 | $5.15 |
Diluted Earnings Per Share | $4.70 | $5.07 |
COMMON SHARES | ||
Basic Shares Outstanding | 52.68M shares | 52.72M shares |
Diluted Shares Outstanding | 53.40M shares | 53.50M shares |
Balance Sheet
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $1.313B | $1.233B |
YoY Change | 50.73% | 47.84% |
Cash & Equivalents | $1.313B | $1.233B |
Short-Term Investments | ||
Other Short-Term Assets | $148.4M | $147.0M |
YoY Change | 15.04% | 6.52% |
Inventory | $995.8M | $965.0M |
Prepaid Expenses | ||
Receivables | $796.4M | $783.5M |
Other Receivables | $746.8M | $729.9M |
Total Short-Term Assets | $4.001B | $3.858B |
YoY Change | 13.23% | 10.83% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $626.3M | $613.6M |
YoY Change | 5.83% | 6.2% |
Goodwill | $1.087B | $1.068B |
YoY Change | 3.62% | 1.65% |
Intangibles | $420.6M | $414.9M |
YoY Change | 4.26% | 1.69% |
Long-Term Investments | ||
YoY Change | ||
Other Assets | $17.10M | $16.90M |
YoY Change | -89.44% | 31.01% |
Total Long-Term Assets | $3.953B | $3.902B |
YoY Change | 6.91% | 7.06% |
TOTAL ASSETS | ||
Total Short-Term Assets | $4.001B | $3.858B |
Total Long-Term Assets | $3.953B | $3.902B |
Total Assets | $7.953B | $7.760B |
YoY Change | 10.0% | 8.9% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $270.0M | $271.1M |
YoY Change | -1.53% | -4.24% |
Accrued Expenses | $592.1M | $585.5M |
YoY Change | -0.47% | -6.06% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $14.30M | $15.70M |
YoY Change | -19.66% | -13.74% |
Long-Term Debt Due | $800.0K | $1.000M |
YoY Change | -52.94% | -47.37% |
Total Short-Term Liabilities | $956.4M | $950.1M |
YoY Change | -0.61% | -4.89% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $1.185B | $1.185B |
YoY Change | -0.03% | 0.09% |
Other Long-Term Liabilities | $87.90M | $86.80M |
YoY Change | -60.72% | 2.84% |
Total Long-Term Liabilities | $1.273B | $1.272B |
YoY Change | -9.66% | 0.28% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $956.4M | $950.1M |
Total Long-Term Liabilities | $1.273B | $1.272B |
Total Liabilities | $2.456B | $2.451B |
YoY Change | -0.72% | -1.69% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | $7.439B | $7.286B |
YoY Change | 12.11% | 12.82% |
Common Stock | $67.50M | $67.50M |
YoY Change | 0.0% | 0.0% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $5.475B | $5.286B |
YoY Change | ||
Total Liabilities & Shareholders Equity | $7.953B | $7.760B |
YoY Change | 10.0% | 8.9% |
Cashflow Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $251.1M | $271.2M |
YoY Change | -4.89% | 9.05% |
Depreciation, Depletion And Amortization | $24.60M | $24.60M |
YoY Change | -0.81% | 36.67% |
Cash From Operating Activities | $274.2M | $301.1M |
YoY Change | 1.44% | -0.17% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $20.40M | $23.20M |
YoY Change | -20.93% | 0.87% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$20.10M | -$37.00M |
YoY Change | -70.78% | -4725.0% |
Cash From Investing Activities | -$40.50M | -$60.20M |
YoY Change | -57.19% | -17.42% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -156.2M | -127.9M |
YoY Change | 14.43% | -15.91% |
NET CHANGE | ||
Cash From Operating Activities | 274.2M | 301.1M |
Cash From Investing Activities | -40.50M | -60.20M |
Cash From Financing Activities | -156.2M | -127.9M |
Net Change In Cash | 77.50M | 113.0M |
YoY Change | 97.7% | 47.52% |
FREE CASH FLOW | ||
Cash From Operating Activities | $274.2M | $301.1M |
Capital Expenditures | $20.40M | $23.20M |
Free Cash Flow | $253.8M | $277.9M |
YoY Change | 3.8% | -0.25% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
350500000 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
343900000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
689700000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
670000000.0 | usd | |
CY2024Q2 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
800000 | shares |
CY2023Q3 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1000000.0 | shares |
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
900000 | shares | |
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1000000.0 | shares | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
51700000 | usd | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
84600000 | usd | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1916000 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
177.79 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
233000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
269.01 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
206000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
170.74 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
26000 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
243.37 | ||
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1917000 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
188.75 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y6M | ||
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
141000000.0 | usd |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1464000 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
169.08 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P4Y4M24D | ||
CY2024Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
135100000 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
55.07 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
51.09 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
22700000 | usd | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
24500000 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
47100000 | usd | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
9500000 | usd | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
9100000 | usd | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
52661542 | shares |
CY2024Q2 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
834342 | shares |
CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
53495884 | shares |
CY2024Q1 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
14900000 | usd |
CY2024Q2 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
3600000 | usd |
CY2024Q2 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
3300000 | usd |
CY2024Q2 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
15200000 | usd |
CY2024Q2 | us-gaap |
Proceeds From Legal Settlements
ProceedsFromLegalSettlements
|
11200000 | usd |
CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
350500000 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
343900000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
689700000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
670000000.0 | usd | |
CY2024Q2 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q2 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false |